Catalyst Wire Dossier Catalyst Wire Dossier

ERBITUX

cetuximab · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

239 regulatory and trial events tracked for ERBITUX, covering 2006-10-26 to 2026-07-15. Get the full timeline:

Most recent: EMA Authorised: Erbitux (cetuximab) — Merck Europe B.V.

See pricing